The Food and Drug Administration has granted approval for the first flu vaccine that uses mRNA technology, according to Moderna. This development opens a path for a new vaccination option aimed at individuals aged 50 and above, targeting protection against influenza.
Moderna revealed that the newly approved vaccine will likely become available at select retailers in the upcoming weeks. This announcement follows discussions and controversies, including skepticism from Robert F. Kennedy Jr. regarding mRNA technology.
A photograph from 2024 shows a researcher working at Moderna’s headquarters in Cambridge, Massachusetts, illustrating the ongoing efforts in mRNA vaccine development.
Church Attendance Linked to Increased Sexual Satisfaction for Married Couples 
Dining with Loved Ones May Benefit Blood Sugar Levels 
Urgent Need for Action in East Africa’s Food Crisis 
Facing Terminal Illness: Embracing Life’s Moments 
Eating with Partners May Impact Blood Sugar Regulation 
Foods Linked to Longevity and Healthier Aging